Global Women’s Health Market to 2027
Global Women’s Health Market to 2027
Global Women’s Health Market Introduction
Women’s health is the essential and important point which provides information regarding health issues of females. Women aged over 60 are suffering from various high risk diseases such as osteoporosis, anemia, menstrual health related problems, osteoarthritis, depression, and obesity to prevent and treat these diseases will increase in the demand for global women’s health market. Further, unhealthy diet and changed lifestyle will have the positive impact on global women’s health market.
Global Women’s Health Market Drivers
Rise in population of women aged over 60 is the major driving factor which is expected to boost the global women’s market growth. Furthermore, increase in government initiatives to improve women’s health and rise in awareness activities will have the positive impact on global women’s health market growth. In addition to that, rise in incidences of higher risk diseases like osteoporosis, anemia, osteoarthritis, menstrual health related disorders, obesity, and depression will improve the demand for women’s health market during this forecast period.
Global Women’s Health Market Restraints
However, lack of awareness and reluctance to use contraceptives are the restraining factor which is expected to hamper the global women’s health market growth.
Global Women’s Health Market Segmentation
Global Women’s Health Market is segmented into product type such as Devices (Vaginal Rings, Intra Uterine Devices, Implants, and Female Condoms), and Drugs (Menopausal Hot Flashes Drugs, and Menopause Drugs), by application such as Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, and Others.
Also, Global Women’s Health Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.
Global Women’s Health Market Key Players
Various key players are discussed in this report such as Amgen, Bayer AG, Eli Lilly and Company, Pfizer, Allergan, Novartis AG, Lupin Limited, Mylan NV,Agile Therapeutics, Allergan, Merck & Co, Johnson & Johnson Services Inc, and Ferring Pharemaceuticals.
Global Women’s Health Market Taxonomy
By Product Type
- Devices
Implants
Intra Uterine Devices
Female Condoms
- Drugs
Menopause Drugs
By Application
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Menopause
- Others
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- 1. Executive Summary
- 1.1. Market Taxonomy
- 2. Global Women’s Health Market Demand (in Value or Size in US$ Mn) Analysis and Forecast
- 3. Market Background
- 3.1. Forecast Factor
- 3.2. Market Dynamics
- 3.2.1. Drivers
- 3.2.2. Challenges
- 3.2.3. Trends
- 4. Global Women’s Health Market Snapshot
- 5. Global Women’s Health Market Analysis, By Types
- 5.1. Y-o-Y Growth Comparison, By Types
- 5.2. Global Women’s Health Market Share Analysis, By Types
- 5.3. Global Women’s Health Market Size and Forecast, By Types
- 5.3.1 Devices
- 5.3.1.1 Vaginal Rings
- 5.3.1.2 Implants
- 5.3.1.3 Intra Uterine Devices
- 5.3.1.4 Female Condoms
- 5.3.2 Drugs
- 5.3.2.1 Menopausal Hot Flashes Drugs
- 5.3.2.2 Menopause Drugs
- 6. Global Women’s Health Market Analysis, By Application
- 6.1. Y-o-Y Growth Comparison, By Application
- 6.2. Global Women’s Health Market Share Analysis, By Application
- 6.3. Global Women’s Health Market Size and Forecast, By Application
- 6.3.1 Postmenopausal Osteoporosis
- 6.3.2 Hormonal Infertility
- 6.3.3 Menopause
- 6.3.4 Others
- 7. Global Women’s Health Market Analysis, By Region
- 7.1. Y-o-Y Growth Comparison, By Region
- 7.2. Global Women’s Health Market Share Analysis, By Region
- 8. North America Women’s Health Market Analysis and Forecast (2017-2027)
- 8.1 Introduction
- 8.2 North America Women’s Health Market Analysis, By Types
- 8.3 North America Women’s Health Market Analysis, By Application
- 8.4 North America Women’s Health Market Analysis, By Country
- 8.4.1 USA
- 8.4.2 Canada
- 8.4.3 Mexico
- 9. Europe Women’s Health Market Analysis and Forecast (2017-2027)
- 9.1 Introduction
- 9.2 Europe Women’s Health Market Analysis, By Types
- 9.3 Europe Women’s Health Market Analysis, By Application
- 9.4 Europe Women’s Health Market Analysis, By Country
- 9.4 .1 Germany
- 9.4 .2 France
- 9.4.3 UK
- 9.4 .4 Rest of Europe
- 10. Asia Pacific Women’s Health Market Analysis and Forecast (2017-2027)
- 10.1 Introduction
- 10.2 Asia Pacific Women’s Health Market Analysis, By Types
- 10.3 Asia Pacific Women’s Health Market Analysis, By Application
- 10.4 Asia Pacific Women’s Health Market Analysis, By Country
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 Rest of Asia Pacific
- 11. Latin America Women’s Health Market Analysis and Forecast (2017-2027)
- 11.1 Introduction
- 11.2 Latin America Women’s Health Market Analysis, By Types
- 11.3 Latin America Women’s Health Market Analysis, By Application
- 12. Middle East & Africa Women’s Health Market Analysis and Forecast (2017-2027)
- 12.1 Introduction
- 12.2 Middle East & Africa Women’s Health Market Analysis, By Types
- 12.3 Middle East & Africa Women’s Health Market Analysis, By Application
- 13. Competition Analysis
- 13.1 Competition Dashboard
- 13.2 Market Share Analysis of Top Vendors
- 13.3 Key Development Strategies
- 14. Company Profiles
- 14.1 Amgen
- 14.1.1 Overview
- 14.1.2 Offerings
- 141.3 Key Financial
- 14.1.4 Business Segment & Geographic Overview
- 14.1.5 Key Market Developments
- 14.1.6 Key Strategies
- 14.2 Bayer AG
- 14.3 Eli Lilly and Company
- 14.4 Pfizer
- 14.5 Allergan
- 14.6 Novartis AG
- 14.7 Lupin Limited
- 14.8 Mylan NV
- 14.9 Agile Therapeutics
- 14.10 Allergan
- 14.11 Merck & Co
- 14.12 Johnson & Johnson Services Inc
- 14.13 Ferring Pharmaceuticals
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook